DE602005016857D1 - Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten - Google Patents

Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten

Info

Publication number
DE602005016857D1
DE602005016857D1 DE602005016857T DE602005016857T DE602005016857D1 DE 602005016857 D1 DE602005016857 D1 DE 602005016857D1 DE 602005016857 T DE602005016857 T DE 602005016857T DE 602005016857 T DE602005016857 T DE 602005016857T DE 602005016857 D1 DE602005016857 D1 DE 602005016857D1
Authority
DE
Germany
Prior art keywords
preparation
production
lhrh antagonists
tripeptide intermediates
tripeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016857T
Other languages
German (de)
English (en)
Inventor
Masakazu Nakazawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of DE602005016857D1 publication Critical patent/DE602005016857D1/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602005016857T 2004-03-09 2005-03-07 Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten Active DE602005016857D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004066256A JP4407322B2 (ja) 2004-03-09 2004-03-09 ペプチドの製造方法

Publications (1)

Publication Number Publication Date
DE602005016857D1 true DE602005016857D1 (de) 2009-11-12

Family

ID=34909384

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016857T Active DE602005016857D1 (de) 2004-03-09 2005-03-07 Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten

Country Status (7)

Country Link
US (2) US7569548B2 (enExample)
EP (1) EP1584625B1 (enExample)
JP (1) JP4407322B2 (enExample)
AT (1) ATE444304T1 (enExample)
DE (1) DE602005016857D1 (enExample)
DK (1) DK1584625T3 (enExample)
ES (1) ES2332655T3 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4407322B2 (ja) * 2004-03-09 2010-02-03 味の素株式会社 ペプチドの製造方法
CN103524599B (zh) * 2012-07-05 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 环肽lhrh拮抗剂衍生物及其药物用途
US12012467B2 (en) 2017-03-28 2024-06-18 Regents Of The University Of Michigan Small molecule DCN1 inhibitors and therapeutic methods using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012488A (en) * 1987-07-31 1989-02-02 Syntex (U.S.A.) Inc. Combination therapy with lhrh antagonist analogs and 19nor progestational steroids
WO1989007450A1 (en) * 1988-02-10 1989-08-24 Abbott Laboratories Lhrh analogs
US5212288A (en) * 1990-02-20 1993-05-18 Syntex (U.S.A.) Inc. Temporary minimal protection synthesis of serine-containing polypeptides
JPH05508859A (ja) * 1990-07-24 1993-12-09 イーストマン コダック カンパニー ペプチド合成方法
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5710247A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process and intermediates for the synthesis of LHRH antagonists
US6013764A (en) 1996-07-17 2000-01-11 Ortho Pharmaceutical Corp. Liquid phase peptide synthesis of KL-4 pulmonary surfactant
AU1590699A (en) * 1997-11-20 1999-06-15 Ortho-Mcneil Pharmaceutical, Inc. Liquid phase process for the preparation of gnrh peptides
SE0104463D0 (sv) * 2001-12-29 2001-12-29 Carlbiotech Ltd As Mellanprodukter för syntes af LHRH-antagonister, sätt att framställa dem och sätt för framställning av LHRH-antagonister
JP4407322B2 (ja) * 2004-03-09 2010-02-03 味の素株式会社 ペプチドの製造方法

Also Published As

Publication number Publication date
US7569548B2 (en) 2009-08-04
US7915224B2 (en) 2011-03-29
EP1584625A1 (en) 2005-10-12
ES2332655T3 (es) 2010-02-10
JP2005255556A (ja) 2005-09-22
DK1584625T3 (da) 2010-02-01
US20050203028A1 (en) 2005-09-15
US20090234098A1 (en) 2009-09-17
JP4407322B2 (ja) 2010-02-03
EP1584625B1 (en) 2009-09-30
ATE444304T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
ATE383436T1 (de) Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen aus der familie der enterobacteriaceae
ATE517190T1 (de) Verfahren zur fermentativen herstellung von 1,5- diaminopentan
ATE443038T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid
ATE544754T1 (de) Verfahren zur herstellung von ivabradinhydrochlorid
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
DE502004001613D1 (de) Verfahren zur herstellung von polyamiden
ATE486844T1 (de) Verfahren zur herstellung von adipodinitril durch hydrocyanierung von 1,3-butadien
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
DE602004020895D1 (de) Verfahren zur herstellung von kohlenstoffnanospulen
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
DE502004005626D1 (de) Verfahren zur herstellung von organoacylphosphiten
ATE365459T1 (de) Verfahren zur herstellung von hochwertigen fermentierten sojabohnenprodukten
ATE455778T1 (de) Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
ATE470657T1 (de) Verfahren zur herstellung von isocyanaten
DE602005016857D1 (de) Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten
DE60309847D1 (de) Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
ATE506342T1 (de) Ein verfahren zur herstellung von tolterodin
DE60318444D1 (de) Verfahren zur herstellung von nevirapin
ATE374755T1 (de) Verfahren zur herstellung von 1,3,5- triazincarbamaten und -harnstoffen
ATE341558T1 (de) Verfahren zur herstellung von topiramate
ATE326545T1 (de) Verfahren zur herstellung von d- oder l-menthol
ATE370950T1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition